This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Medical treatment

Authoring team

Initially majority of patients will respond to lifestyle interventions and a trial of betahistines for three months

Managing an acute attack (1)

  • the patient should lay down on a firm surface during the acute attack
  • should stay as motionless as possible, with the eyes open and fixed on a stationary object
  • drinking or sipping water should be avoided (this may cause vomiting)
  • the patient should be kept like this until the severe vertigo is passed
  • may get up very slowly, once the vertigo disappears.
  • during an acute attack of Meniere's disease, the patient is likely to vomit

  • oral medication used to suppress the symptoms of acute vestibular attacks (vestibular sedatives) include
    • cinnarizine, 15-30 mg t.d.s. or
    • phenothiazines such as prochlorperazine 5-10mg tds - regular long term basis is not recommended, or
    • promethazine, cyclizine, or,
    • metoclopramide, or,
    • benzodiazepine – can be used with caution for short periods

Measures for prevention of acute attacks

  • lifestyle interventions (dietary control) - the goal is to provide stable body fluid/blood levels to avoid secondary fluctuations in the inner ear fluid
    • food and fluid intake should be even throughout the day
    • foods or fluids that have a high salt content should be avoided
    • there should be adequate intake of fluids daily
      • may contain water, milk and low-sugar fruit juices
    • caffeine-containing fluids and foods (coffee, tea and chocolate) should be avoided.
    • alcohol intake should be limited to one glass of beer or wine each day
    • foods containing MSG (monosodium glutamate)also should be avoided
    • reducing or stopping smoking

  • medical management
    • betahistine
      • a starting dose of 16 mg three times a day will result in a reduction of the frequency and severity of attacks
      • however there is limited evidence for a strong effect of betahistine in preventing attacks

    • diuretics
      • although there is lack of evidence to support their use, diuretics may sometimes be offered to patients based on the biological model of endolymphatic hydrops

    • corticosteroids
      • both oral steroids and intratympanic steroid injections have been used in the treatment of acute and chronic symptoms

    • medical ablation
      • used in patients with intractable vertigo
      • intratympanic use of aminoglycosides (gentamicinin) to relieve vertigo and preservation of hearing s(1,2,3)

Other treatment options used in Meniere's disease include:

  • vestibular rehabilitation
    • physical therapy used to improve vestibular function and mechanisms of central adaptation and compensation
    • may include Cawthorne-Cooksey exercises and low-impact exercise, such as cycling or walking
    • useful in patients with stable, non-fluctuating vestibular loss
  • adjunctive therapy - psychological or psychiatric intervention, e.g.- cognitive behavioural therapy, and techniques such as relaxation and breathing exercises
  • pressure pulse treatment
    • is a non invasive methodised for intractable vertigo in patients with Meniere’s disease
    • positive pressure provided through a pulse-generator into the ear canal (1,2,3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.